AGITG MASTERPLAN: a randomised phase II study of modified FOLFIRINOX alone or in combination with stereotactic body radiotherapy for patients with high-risk and locally advanced pancreatic cancer https://t.co/xgrSyV7Nyw https://t.co/oFWvTnenQ2
192 followers
556 followers
AGITG MASTERPLAN: a randomised phase II study of modified FOLFIRINOX alone or in combination with stereotactic body radiotherapy for patients with high-risk and locally advanced pancreatic cancer https://t.co/q503DT9pfm https://t.co/mu3ifc6s9S
906 followers
New article: AGITG MASTERPLAN: a randomised phase II study of modified FOLFIRINOX alone or in combination with stereotactic body radiotherapy for patients with high-risk and locally advanced pancreatic cancer https://t.co/5X9xI49Xxj #pancreaticcancer #onco